Related Experiment Video
Updated: May 6, 2026

05:47
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
1.9K
ReVeaLD: a user-driven domain-specific interactive search platform for biomedical research
Maulik R Kamdar1, Dimitris Zeginis2, Ali Hasnain1
1Digital Enterprise Research Institute (DERI), National University of Ireland, Galway, Ireland.
Journal of Biomedical Informatics
|October 19, 2013
Summary
ReVeaLD, a visual analytics platform, simplifies complex bioinformatics data exploration for researchers. It enables intuitive querying of distributed data sources using a domain-specific language, enhancing semantic web technology adoption.
Area of Science:
- Bioinformatics and Computational Biology
- Biomedical Data Integration
- Visual Analytics
Background:
- Life sciences specialization and increased biomedical datasets necessitate advanced data discovery methods.
- Semantic web technologies offer potential for data integration but face usability challenges for non-technical researchers.
- Intuitive interaction with distributed data sources is crucial for biomedical experts to exploit integrated information.
Purpose of the Study:
- To introduce ReVeaLD (Real-time Visual Explorer and Aggregator of Linked Data), a user-centered visual analytics platform.
- To enhance intuitive interaction with data from distributed sources for biomedical researchers.
- To improve the usability of semantic web technologies in bioinformatics research.
Main Methods:
- Developed a user-centered visual analytics platform (ReVeaLD) using Scalable Vector Graphics and JavaScript.
- Implemented a domain-specific language (DSL) for query formulation, mapped to a self-updating catalogue of external data elements.
- Designed user-defined graphic rules for information display via media-rich interfaces.
- Evaluated the platform through a game-based assessment with biomedical researchers formulating challenge questions.
Main Results:
- ReVeaLD facilitates intuitive interaction with distributed data sources.
- Complex queries were formulated in under two minutes by researchers unfamiliar with the platform.
- Supporting domain-specific language (DSL) element identification significantly improved platform intuitiveness and usability.
Conclusions:
- ReVeaLD enhances the ability of biomedical researchers to discover and correlate data from diverse sources.
- The platform demonstrates the potential of visual analytics and domain-specific languages to bridge the gap in semantic web technology adoption.
- ReVeaLD offers a promising solution for more accessible and efficient biomedical data exploration.
Related Concept Videos
Drug Discovery: Overview
10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Genetic Screens
4.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.6K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K

